Immunotherapy Drives Mesenchymal Tumor Cell State Shift and TME Immune Response in Glioblastoma Patients

Investigators present the integrative paired single-cell RNA-seq analysis of 76 tumor samples from patients in a clinical trial of the PD-1 inhibitor nivolumab and untreated patients.